MARKET

CMRX

Chimerix
CMRX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.1869
3713.04
6.47
801,084,844.84
Jazz Pharmaceuticals Q2 revenue up 2%
Reuters · 08/05 20:46
Jazz Pharmaceuticals Reports Q2 2025 Revenues of $1.05 Billion and Significant Non-GAAP Adjusted Net Loss of $504.8 Million, EPS Drops to $(8.25)
Reuters · 08/05 20:11
Chimerix Terminates Loan and Delists from Nasdaq
TipRanks · 04/21 20:52
Weekly Report: what happened at CMRX last week (0414-0418)?
Weekly Report · 04/21 10:39
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
NASDAQ · 04/17 11:49
Weekly Report: what happened at CMRX last week (0407-0411)?
Weekly Report · 04/14 10:32
Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data
Seeking Alpha · 04/12 15:00
Catalyst Watch: Meta takes on the FTC, Taiwan Semi earnings, and Amazon satellites take flight
Seeking Alpha · 04/11 19:00
More

Webull offers Chimerix stock information, including NASDAQ: CMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMRX stock methods without spending real money on the virtual paper trading platform.